Journal of Clinical and Translational Hepatology

Papers
(The TQCC of Journal of Clinical and Translational Hepatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver53
Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options47
NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States36
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review33
Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis33
Macrophage Phenotypes and Hepatitis B Virus Infection30
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease29
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study28
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD27
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak21
Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications20
Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study20
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?20
Antihepatic Fibrosis Drugs in Clinical Trials19
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy18
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review18
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome18
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications17
Statin-induced Liver Injury Patterns: A Clinical Review17
Management of Hepatorenal Syndrome: A Review16
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis16
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease15
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease14
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma14
Guidelines for Prevention and Treatment of Chronic Hepatitis B14
COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery14
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update12
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail12
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease12
Body Building and Aminotransferase Elevations: A Review11
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists11
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice11
Prevention of HBV Recurrence after Liver Transplant: A Review11
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts11
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome10
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence10
A 3D Human Liver Model of Nonalcoholic Steatohepatitis10
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges10
Infections in Alcoholic Hepatitis10
Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis10
Guidelines for the Management of Cholestatic Liver Diseases (2021)9
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment9
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review9
HEV and HBV Dual Infection: A Review9
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway9
Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease9
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally9
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates9
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis9
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City9
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma8
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)8
A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps8
Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B8
Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis7
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling7
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update7
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review7
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis7
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure7
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review7
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases7
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease7
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence7
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science7
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies7
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies7
Clinical Considerations of Coagulopathy in Acute Liver Failure7
Selective Androgen Receptor Modulators: An Emerging Liver Toxin7
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver7
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment7
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation7
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection7
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China7
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?7
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA7
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis7
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study7
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?7
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 20197
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)6
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma6
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice6
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease6
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions6
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice6
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure6
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China6
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy6
Update on Sphincter of Oddi Dysfunction: A Review6
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma6
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective6
Hepatic Histoplasmosis: An Update6
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease6
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning6
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype6
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection6
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition6
Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time5
Elastography for Longitudinal Assessment of Liver Fibrosis after Antiviral Therapy: A Review5
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma5
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection5
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis5
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life5
Autotaxin: An Early Warning Biomarker for Acute-on-chronic Liver Failure5
Erythroid Lineage Cells in the Liver: Novel Immune Regulators and Beyond5
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)5
Noncanonical NF-κB Signaling Pathway in Liver Diseases5
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis5
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop5
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver5
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination5
2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus5
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China5
Coronavirus Disease-2019 (COVID-19) and the Liver5
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site5
Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics5
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma5
Targeted Mitochondrial Delivery to Hepatocytes: A Review5
Functional Cure of Chronic Hepatitis B with Antiviral Treatment in Children having High-level Viremia and Normal or Mildly Elevated Serum Aminotransferase4
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection4
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?4
Alcohol and Metabolic-associated Fatty Liver Disease4
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study4
Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome4
Nonalcoholic Fatty Liver Disease after Liver Transplant4
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease4
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome4
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions4
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma4
Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians4
Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis4
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis4
Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis4
Regulatory Effect of JAK2/STAT3 on the Immune Function of Endotoxin-tolerant Dendritic Cells and its Involvement in Acute Liver Failure4
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease4
Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis4
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India4
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase4
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway4
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center4
Diagnostic Accuracy of the Apparent Diffusion Coefficient for Microvascular Invasion in Hepatocellular Carcinoma: A Meta-analysis4
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma4
The Gut Microbiome and Ferroptosis in MAFLD4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy4
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation4
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment4
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research4
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo4
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis4
0.063436031341553